Whole genome sequencing to help you improve your health and longevity. $999. U.S. price.
A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.
Screening test of 26 genes, including BRCA1 and BRCA2, for increased risk of developing breast, ovarian, and other inherited cancers.
Maternal blood-based non-invasive screening that predicts the presence of Down Syndrome (T21), Edwards Syndrome (T18), and Patau Syndrome (T13).
Saliva-based screening of prospective or currently pregnant parents to see if they carry inherited and rare conditions such as cystic fibrosis.
Comprehensive genetic screening of newborns for early childhood diseases.
Industry-leading genetic tests, whole genome sequencing, and interpretation for your patients.
Customized, fully integrated, research-only whole genome sequencing services.
Industry-leading genetic tests and genome sequencing solutions.
As pioneers in consumer genetics, we support healthcare professionals in helping their patients proactively manage their disease risk.
Simple process to create and manage your personal account
Capability to order individual tests and/or in batches for different locations
Kits with clear instructions on how to collect samples
Easy to use portal to access and print individual reports or in batches
Email and phone support
All tests run in a clinically validated laboratory following strict adherence to CLIA guidelines.
Targeted diagnostic testing
Whole genome sequencing
Anywhere in the world.
Genetic testing based on U.S. regulations
Designed to support physician-patient relationship.
Let us know. Our team will get in touch with you.